359 related articles for article (PubMed ID: 19178759)
21. Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy.
Lai PS; Lou PJ; Peng CL; Pai CL; Yen WN; Huang MY; Young TH; Shieh MJ
J Control Release; 2007 Sep; 122(1):39-46. PubMed ID: 17628166
[TBL] [Abstract][Full Text] [Related]
22. Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy.
Bisht S; Maitra A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(4):415-25. PubMed ID: 20049807
[TBL] [Abstract][Full Text] [Related]
23. Pegylated liposomal doxorubicin in ovarian cancer.
Green AE; Rose PG
Int J Nanomedicine; 2006; 1(3):229-39. PubMed ID: 17717964
[TBL] [Abstract][Full Text] [Related]
24. Injectable chitosan hydrogels for localised cancer therapy.
Ta HT; Dass CR; Dunstan DE
J Control Release; 2008 Mar; 126(3):205-16. PubMed ID: 18258328
[TBL] [Abstract][Full Text] [Related]
25. DNA/chitosan nanocomplex as a novel drug carrier for doxorubicin.
Cheng X; Zhang F; Zhou G; Gao S; Dong L; Jiang W; Ding Z; Chen J; Zhang J
Drug Deliv; 2009 Apr; 16(3):135-44. PubMed ID: 19514973
[TBL] [Abstract][Full Text] [Related]
26. Single-phased luminescent mesoporous nanoparticles for simultaneous cell imaging and anticancer drug delivery.
Di W; Ren X; Zhao H; Shirahata N; Sakka Y; Qin W
Biomaterials; 2011 Oct; 32(29):7226-33. PubMed ID: 21745687
[TBL] [Abstract][Full Text] [Related]
27. Novel biodegradable HSAM nanoparticle for drug delivery.
Liu B; Jiang S; Zhang W; Ye F; Wang YH; Wu J; Zhang DY
Oncol Rep; 2006 Apr; 15(4):957-61. PubMed ID: 16525685
[TBL] [Abstract][Full Text] [Related]
28. Chitosan-based hydrogels for nasal drug delivery: from inserts to nanoparticles.
Luppi B; Bigucci F; Cerchiara T; Zecchi V
Expert Opin Drug Deliv; 2010 Jul; 7(7):811-28. PubMed ID: 20560778
[TBL] [Abstract][Full Text] [Related]
29. [In vitro experimental study of adriamycin-loaded chitosan drug delivery system].
Zhang Y; Hou C; Chen A
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 1997 Sep; 11(5):309-11. PubMed ID: 9867937
[TBL] [Abstract][Full Text] [Related]
30. Review paper: chitosan derivatives as promising materials for controlled drug delivery.
Prabaharan M
J Biomater Appl; 2008 Jul; 23(1):5-36. PubMed ID: 18593819
[TBL] [Abstract][Full Text] [Related]
31. Mucosal delivery of liposome-chitosan nanoparticle complexes.
Carvalho EL; Grenha A; Remuñán-López C; Alonso MJ; Seijo B
Methods Enzymol; 2009; 465():289-312. PubMed ID: 19913173
[TBL] [Abstract][Full Text] [Related]
32. Poly(amidoamine) conjugates containing doxorubicin bound via an acid-sensitive linker.
Lavignac N; Nicholls JL; Ferruti P; Duncan R
Macromol Biosci; 2009 May; 9(5):480-7. PubMed ID: 19016501
[TBL] [Abstract][Full Text] [Related]
33. Potential applications of chitosan in veterinary medicine.
Senel S; McClure SJ
Adv Drug Deliv Rev; 2004 Jun; 56(10):1467-80. PubMed ID: 15191793
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in the field of nanometric drug carriers.
Ogier J; Arnauld T; Doris E
Future Med Chem; 2009 Jul; 1(4):693-711. PubMed ID: 21426033
[TBL] [Abstract][Full Text] [Related]
35. Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery.
Li X; Guo Q; Zheng X; Kong X; Shi S; Chen L; Zhao X; Wei Y; Qian Z
Drug Deliv; 2009 Apr; 16(3):160-6. PubMed ID: 19514976
[TBL] [Abstract][Full Text] [Related]
36. Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery.
Duceppe N; Tabrizian M
Expert Opin Drug Deliv; 2010 Oct; 7(10):1191-207. PubMed ID: 20836623
[TBL] [Abstract][Full Text] [Related]
37. Chitosan and its salts for mucosal and transmucosal delivery.
Bonferoni MC; Sandri G; Rossi S; Ferrari F; Caramella C
Expert Opin Drug Deliv; 2009 Sep; 6(9):923-39. PubMed ID: 19637983
[TBL] [Abstract][Full Text] [Related]
38. The potential of chitosan for the oral administration of peptides.
Prego C; Torres D; Alonso MJ
Expert Opin Drug Deliv; 2005 Sep; 2(5):843-54. PubMed ID: 16296782
[TBL] [Abstract][Full Text] [Related]
39. [Applications of chitosan and its derivatives in pharmaceutical industry of Chinese medicine].
Wang LH; Wu GL; Cheng YY
Zhongguo Zhong Yao Za Zhi; 2004 Apr; 29(4):289-92. PubMed ID: 15706858
[TBL] [Abstract][Full Text] [Related]
40. Novel method of doxorubicin-SPION reversible association for magnetic drug targeting.
Munnier E; Cohen-Jonathan S; Linassier C; Douziech-Eyrolles L; Marchais H; Soucé M; Hervé K; Dubois P; Chourpa I
Int J Pharm; 2008 Nov; 363(1-2):170-6. PubMed ID: 18687392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
